Health Care/Hospital

Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk Multiple Myeloma, Treatment Challenges and Dual-Targeting CAR-T with Overnight Manufacturing - a Novel Approach for Treatment of Multiple Myeloma

SUZHOU, China and PALO ALTO, Calif., May 26, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...

2021-05-26 21:00 9335

IT Tech Packaging, Inc. Officially Obtains FDA Approval for Surgical Mask Products

BAODING, China, May 26, 2021 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE AMERICAN: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today announced that the Company has officially obtained approval for surgical mask...

2021-05-26 20:00 13334

Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand

- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine   DARMSTADT,...

2021-05-26 20:00 775

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...

2021-05-26 19:12 7748

TIAN RUIXIANG Holdings Ltd Signs Insurance Brokerage Services Agreement for Cooperation in Cancer Prevention Insurance

BEIJING, May 26, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), aChina-based insurance broker, announces today that it has been commissioned by Zhongkang Yiyang (Beijing) Health Technology Co., Ltd.("Zhongkang"), a company providing technology and health managemen...

2021-05-26 18:30 12773

Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US

BALTIMORE, May 26, 2021 /PRNewswire/ -- Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, today announces that it has initiated the first-in-human ("FIH") Phase I clinical trial of PSP001 in US. PSP001 is a novel, long acting and potent interferon ...

2021-05-26 16:10 485

IntoCare Medical Completes Up to 100 million RMB Round D Financing, Doubling Down on Powered Stapling Industry

SUZHOU, China, May 26, 2021 /PRNewswire/ -- IntoCare Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "IntoCare"), a global pioneer in Powered Surgical Staplers, today announced the completion of up to100 million RMB round D financing. Qiming Venture Partners led the investment w...

2021-05-26 12:20 1118

How Guiyang Leverages Big Data Analytics in Healthcare?

GUIYANG, China, May 26, 2021 /PRNewswire/ -- Wang Lei clicked on an app called Healthy Guiyang and checked her blood test result. As a resident in Guanshanhu District,Guiyang, he told a journalist at Huanqiu.com, "In the past, we need to collect the healthcare report in medical-based institutions...

2021-05-26 11:08 1020

TCI Co., Ltd. named as one of Asia's fastest growing companies by The Financial Times

TAIPEI, May 25, 2021 /PRNewswire/ -- TCI Co., Ltd. (8436. TWO), a leading nutraceutical ODM company, has earned a position in the exclusive ranking of High-Growth Companies inAsia-Pacific 2021. TCI, has been ranked top 15 among Taiwanese companies, registering an absolute growth rate of 207.6% an...

2021-05-26 11:07 1148

Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation

AUSTIN, Texas, May 26, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center participated in a clinical study to evaluate the safety and effectiveness of a new lattice sphere catheter designed to optimize procedural efficiency and efficacy ...

2021-05-26 10:13 933

UNNC students win international awards with sustainable design works

NINGBO, China, May 26, 2021 /PRNewswire/ -- Home pregnancy test kits are typically made from plastic, and their consumption contributes to a large amount of plastic waste every year. A University of Nottingham Ningbo China (UNNC) graduate, Ruiheng Lan, and an academic staff member, DrXu Sun propo...

2021-05-26 09:00 876

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

- Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacin - Lefamulin was generally safe an...

2021-05-26 05:00 1126

I Peace's cell manufacturing facility "Peace Engine Kyoto" receives third-party certification as US cGMP compliant: the facility now meets the standard for both the US and Japanese markets

PALO ALTO, Calif., May 25, 2021 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up focusing on Nobel Prize-winning technology "induced pluripotent stem cells (iPSCs)" received a third-party certification as US FDA cGMP compliant for its manufacturing facility "Pea...

2021-05-26 03:00 667

Aussie LegalTech Startup Goes Global With COVID-19 Diagnosis Tool

* Australian LegalTech startup, Rulestar, is taking its automation platform global and expanding beyond the legal industry. * Rulestar has released an automated COVID-19 diagnosis tool as a new proof-of-concept product. * This demonstrates how automation technologies can improve decision-mak...

2021-05-25 22:25 843

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

HELSINKI, May 25, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Celanese Corporation (NYSE: CE), a global specialty materials company, today announced plans to explore the synergies between their respective technologies in the field of nanop...

2021-05-25 21:45 1066

OptraSCAN Announces CytoSiA - A Complete Digital Solution For Scanning And Analysis Of Cytology Slides At Affordable Pricing

- OptraSCAN's Intelligent Tool CytoSiA – To Advance Cytology Screening Through Unmatched Image Quality And Artificial Intelligence Based Image Analysis Solution SAN JOSE, Calif. and PUNE, India, May 25, 2021 /PRNewswire/ -- OptraSCAN ®, the leading On-Demand Digital P...

2021-05-25 21:27 1524

Spinal Stabilization Technologies Ltd Earns CE Mark, FDA "Breakthrough Designation" For PerQdisc Nucleus Replacement System For Degenerative Disc Disease

KILKENNY, Ireland, May 25, 2021 /PRNewswire/ -- Spinal Stabilization Technologies, Ltd. (SST),Kilkenny, Ireland announced today that it has earned the CE Mark and the FDA's "breakthrough designation" for its PerQdisc™ Nucleus Replacement System. PerQdisc is the only commercially available lumbar...

2021-05-25 21:09 958

Aon's New Vaccine Supply Chain Solution to Benefit Response Fund for the World Health Organization

Aon will donate all 2021 revenues from new solution that protects global COVID-19 vaccine shipments to the COVID-19 Solidarity Response Fund. CHICAGO, May 25, 2021 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and hea...

2021-05-25 21:00 5614

Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite

SAN DIEGO, May 25, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it will soon open a high speed multi-purpose fill finish line in its state-of-the-art commercial manuf...

2021-05-25 20:05 628

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Pilot CRS Study to Evaluate Performance of Novel Aortix device in Australia and the U.S. HOUSTON, May 25, 2021 /PRNewswire/ -- Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the fir...

2021-05-25 19:02 562
1 ... 11121314151617 ... 1008